Pentagastrin | CAS#5534-95-2 | ASFV drug

MedKoo Cat#: 318464 | Name: Pentagastrin

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Pentagastrin is a synthetic polypeptide that has effects like gastrin when given parenterally. It stimulates the secretion of gastric acid, pepsin, and intrinsic factor, and has been used as a diagnostic aid as the pentagastrin-stimulated calcitonin test. Pentagastrin binds to the cholecystokinin-B receptor, which is expressed widely in the brain. Activation of these receptors activates the phospholipase C second messenger system. Pentagastrin is a potential antiviral drug against ASFV.

Chemical Structure

Pentagastrin

CAS#5534-95-2

Theoretical Analysis

MedKoo Cat#: 318464

Name: Pentagastrin

CAS#: 5534-95-2

Chemical Formula: C37H49N7O9S

Exact Mass: 767.3313

Molecular Weight: 767.89

Elemental Analysis: C, 57.87; H, 6.43; N, 12.77; O, 18.75; S, 4.18

Price and Availability

Size	Price	Availability	Quantity
25mg	USD 250.00
50mg	USD 450.00
100mg	USD 750.00

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

No Data

Synonym

Pentagastrin; CHEMBL1328; ICI-50123; DSSTox_CID_28918; DSSTox_RID_83185; DSSTox_GSID_48992; NCGC00183362-01; NCGC00183362-02; Gastrodiagnost; Pentagastrinum; Peptavlon; Petogasrin;

IUPAC/Chemical Name

(3S)-4-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-[[(2S)-2-[[(2S)-3-(1H-indol-3-yl)-2-[3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoylamino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]-4-oxobutanoic acid

InChi Key

NEYNJQRKHLUJRU-DZUOILHNSA-N

InChi Code

InChI=1S/C37H49N7O9S/c1-37(2,3)53-36(52)39-16-14-30(45)41-28(19-23-21-40-25-13-9-8-12-24(23)25)34(50)42-26(15-17-54-4)33(49)44-29(20-31(46)47)35(51)43-27(32(38)48)18-22-10-6-5-7-11-22/h5-13,21,26-29,40H,14-20H2,1-4H3,(H2,38,48)(H,39,52)(H,41,45)(H,42,50)(H,43,51)(H,44,49)(H,46,47)/t26-,27-,28-,29-/m0/s1

SMILES Code

CC(C)(C)OC(=O)NCCC(=O)NC(CC1=CNC2=CC=CC=C21)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CC3=CC=CC=C3)C(=O)N

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO, not in water

Shelf Life

>2 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 767.89 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Namikawa K, Björnsson ES. Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive? Int J Mol Sci. 2024 May 17;25(10):5459. doi: 10.3390/ijms25105459. PMID: 38791497; PMCID: PMC11122117. 2: Choi J, Lee H, Cho S, Choi Y, Pham TX, Huynh TTX, Lim YS, Hwang SB. Polygalic acid inhibits african swine fever virus polymerase activity: findings from machine learning and in vitro testing. J Comput Aided Mol Des. 2023 Sep;37(9):453-461. doi: 10.1007/s10822-023-00520-6. Epub 2023 Jul 15. PMID: 37452977. 3: Yang K, Jin H, Gao X, Wang GC, Zhang GQ. Elucidating the molecular determinants in the process of gastrin C-terminal pentapeptide amide end activating cholecystokinin 2 receptor by Gaussian accelerated molecular dynamics simulations. Front Pharmacol. 2023 Jan 23;13:1054575. doi: 10.3389/fphar.2022.1054575. PMID: 36756145; PMCID: PMC9899899. 4: Aksoydan B, Durdagi S. Virtual drug repurposing study for the CGRPR identifies pentagastrin and leuprorelin as putative candidates. J Mol Graph Model. 2022 Nov;116:108254. doi: 10.1016/j.jmgm.2022.108254. Epub 2022 Jun 18. PMID: 35803082. 5: Dubey A, Saini S, Sharma V, Malik H, Kumar D, De AK, Bhattacharya D, Malakar D. Deducing Insulin-Producing Cells from Goat Adipose Tissue-Derived Mesenchymal Stem Cells. Cell Reprogram. 2022 Aug;24(4):195-203. doi: 10.1089/cell.2022.0029. Epub 2022 Jul 5. PMID: 35787695. 6: Kiriakopoulos A, Giannakis P, Menenakos E. Calcitonin: current concepts and differential diagnosis. Ther Adv Endocrinol Metab. 2022 May 21;13:20420188221099344. doi: 10.1177/20420188221099344. PMID: 35614985; PMCID: PMC9125613. 7: Choi J, Tark D, Lim YS, Hwang SB. Identification of African Swine Fever Virus Inhibitors through High Performance Virtual Screening Using Machine Learning. Int J Mol Sci. 2021 Dec 14;22(24):13414. doi: 10.3390/ijms222413414. PMID: 34948216; PMCID: PMC8703626. 8: Choi J, Yun JS, Song H, Shin YK, Kang YH, Munashingha PR, Yoon J, Kim NH, Kim HS, Yook JI, Tark D, Lim YS, Hwang SB. Prediction of African Swine Fever Virus Inhibitors by Molecular Docking-Driven Machine Learning Models. Molecules. 2021 Jun 11;26(12):3592. doi: 10.3390/molecules26123592. PMID: 34208385; PMCID: PMC8231271. 9: Băetu M, Olariu CA, Moldoveanu G, Corneci C, Badiu C. Calcitonin Stimulation Tests: Rationale, Technical Issues and Side Effects: A Review. Horm Metab Res. 2021 Jun;53(6):355-363. doi: 10.1055/a-1487-6449. Epub 2021 Jun 21. PMID: 34154026. 10: Xie Y, Liu H, Chen X, Xing J. The Effect of Gastric pH on the Pharmacokinetics-pharmacodynamics of Naphthoquine in Rodents, as well as in Human Predicted Using a PBPK Model. Curr Drug Metab. 2021;22(5):363-371. doi: 10.2174/1389200222666210129102411. PMID: 33511926. 11: Shah J, Bush N, Rajan K, Nain CK, Singh K, Kochhar R. Gastric secretion in patients with caustic ingestion: A prospective study. Indian J Gastroenterol. 2021 Feb;40(1):50-55. doi: 10.1007/s12664-020-01116-w. Epub 2021 Jan 8. PMID: 33417177. 12: Kartal Baykan E, Erdoğan M. Basal and pentagastrin-stimulated calcitonin cut-off values in diagnosis of preoperative medullary thyroid cancer. Turk J Med Sci. 2021 Apr 30;51(2):650-656. doi: 10.3906/sag-2003-182. PMID: 33128357; PMCID: PMC8203141. 13: Balakrishnan V, Lakshminarayanan K. Screening of FDA Approved Drugs Against SARS-CoV-2 Main Protease: Coronavirus Disease. Int J Pept Res Ther. 2021;27(1):651-658. doi: 10.1007/s10989-020-10115-6. Epub 2020 Sep 28. PMID: 33013255; PMCID: PMC7521772. 14: Achilonu I, Iwuchukwu EA, Achilonu OJ, Fernandes MA, Sayed Y. Targeting the SARS-CoV-2 main protease using FDA-approved Isavuconazonium, a P2-P3 α-ketoamide derivative and Pentagastrin: An in-silico drug discovery approach. J Mol Graph Model. 2020 Dec;101:107730. doi: 10.1016/j.jmgm.2020.107730. Epub 2020 Sep 2. PMID: 32920239; PMCID: PMC7462840. 15: Durk MR, Jones NS, Liu J, Nagapudi K, Mao C, Plise EG, Wong S, Chen JZ, Chen Y, Chinn LW, Chiang PC. Understanding the Effect of Hydroxypropyl-β-Cyclodextrin on Fenebrutinib Absorption in an Itraconazole-Fenebrutinib Drug-Drug Interaction Study. Clin Pharmacol Ther. 2020 Dec;108(6):1224-1232. doi: 10.1002/cpt.1943. Epub 2020 Jul 18. PMID: 32535897; PMCID: PMC7689742. 16: Gesenberg C, Mathias NR, Xu Y, Crison J, Savant I, Saari A, Good DJ, Hemenway JN, Narang AS, Schartman RR, Zheng N, Buzescu A, Patel J. Utilization of In Vitro, In Vivo and In Silico Tools to Evaluate the pH-Dependent Absorption of a BCS Class II Compound and Identify a pH-Effect Mitigating Strategy. Pharm Res. 2019 Oct 21;36(12):164. doi: 10.1007/s11095-019-2698-0. PMID: 31637544. 17: Gambardella C, Offi C, Patrone R, Clarizia G, Mauriello C, Tartaglia E, Di Capua F, Di Martino S, Romano RM, Fiore L, Conzo A, Conzo G, Docimo G. Calcitonin negative Medullary Thyroid Carcinoma: a challenging diagnosis or a medical dilemma? BMC Endocr Disord. 2019 May 29;19(Suppl 1):45. doi: 10.1186/s12902-019-0367-2. PMID: 31142313; PMCID: PMC6541563. 18: Šíma M, Kutinová-Canová N, Ryšánek P, Hořínková J, Moškořová D, Slanař O. Gastric pH in Rats: Key Determinant for Preclinical Evaluation of pH-dependent Oral Drug Absorption. Prague Med Rep. 2019;120(1):5-9. doi: 10.14712/23362936.2019.5. PMID: 31103048. 19: Dillon C, Hughes H, O'Reilly NJ, Allender CJ, Barrow DA, McLoughlin P. Dissolving microneedle based transdermal delivery of therapeutic peptide analogues. Int J Pharm. 2019 Jun 30;565:9-19. doi: 10.1016/j.ijpharm.2019.04.075. Epub 2019 Apr 29. PMID: 31047995. 20: Koziolek M, Grimm M, Bollmann T, Schäfer KJ, Blattner SM, Lotz R, Boeck G, Weitschies W. Characterization of the GI transit conditions in Beagle dogs with a telemetric motility capsule. Eur J Pharm Biopharm. 2019 Mar;136:221-230. doi: 10.1016/j.ejpb.2019.01.026. Epub 2019 Jan 28. PMID: 30703546.